|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Napier KJ, Scheerer M and Misra S:
Esophageal cancer: A Review of epidemiology, pathogenesis, staging
workup and treatment modalities. World J Gastrointest Oncol.
6:112–120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wen SW, Zhang YF, Li Y, Liu ZX, Lv HL, Li
ZH, Xu YZ, Zhu YG and Tian ZQ: Characterization and effects of
miR-21 expression in esophageal cancer. Genet Mol Res.
14:8810–8818. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gabra MM and Salmena L: microRNAs and
acute myeloid leukemia chemoresistance: A mechanistic overview.
Front Oncol. 7:2552017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cheng L, Zhan B, Luo P and Wang B:
miRNA375 regulates the cell survival and apoptosis of human
nonsmall cell carcinoma by targeting HER2. Mol Med Rep.
15:1387–1392. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Poltronieri P: Editorial: Overview on
microRNAs in cancer development and virus infection. Microrna.
5:80–82. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tutar L, Tutar E and Tutar Y: MicroRNAs
and cancer; an overview. Curr Pharm Biotechnol. 15:430–437. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rauhala HE, Jalava SE, Isotalo J, Bracken
H, Lehmusvaara S, Tammela TL, Oja H and Visakorpi T: miR-193b is an
epigenetically regulated putative tumor suppressor in prostate
cancer. Int J Cancer. 127:1363–1372. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen J, Feilotter HE, Paré GC, Zhang X,
Pemberton JG, Garady C, Lai D, Yang X and Tron VA: MicroRNA-193b
represses cell proliferation and regulates cyclin D1 in melanoma.
Am J Pathol. 176:2520–2529. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li XF, Yan PJ and Shao ZM: Downregulation
of miR-193b contributes to enhance urokinase-type plasminogen
activator (uPA) expression and tumor progression and invasion in
human breast cancer. Oncogene. 28:3937–3948. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hummel R, Sie C, Watson DI, Wang T, Ansar
A, Michael MZ, Van der Hoek M, Haier J and Hussey DJ: MicroRNA
signatures in chemotherapy resistant esophageal cancer cell lines.
World J Gastroenterol. 20:14904–14912. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nyhan MJ, O'Donovan TR, Boersma AW, Wiemer
EA and McKenna SL: MiR-193b promotes autophagy and non-apoptotic
cell death in oesophageal cancer cells. BMC Cancer. 16:1012016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gupta B and Kumar N: Worldwide incidence,
mortality and time trends for cancer of the oesophagus. Eur J
Cancer Prev. 26:107–118. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Petty RD, Dahle-Smith A, Stevenson DAJ,
Osborne A, Massie D, Clark C, Murray GI, Dutton SJ, Roberts C,
Chong IY, et al: Gefitinib and EGFR gene copy number aberrations in
esophageal cancer. J Clin Oncol. 35:2279–2287. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang R, Li Y, Chen Y, Liu X, Wang Z, Sun
H, Zheng Y, Ding Z, Lan L, Li M, et al: Clinical implications of
the concentration and EGFR/KRAS mutations of plasma cell free DNA
of patients with lung cancer and esophageal cancer. Zhonghua Yi Xue
Za Zhi. 95:3839–3842. 2015.(In Chinese). PubMed/NCBI
|
|
17
|
Liu P, Feng Y, Dong D, Liu X, Chen Y, Wang
Y and Zhou Y: Enhanced renoprotective efect of IGF-1 modifed human
umbilical cord-derived mesenchymal stem cells on gentamicin-induced
acute kidney injury. Sci Rep. 6:202872016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu P, Cai J, Dong D, Chen Y, Liu X, Wang
Y and Zhou Y: Effects of SOX2 on proliferation, migration and
adhesion of human dental pulp stem cells. PLoS One.
10:e01413462015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu P, Chen S, Li X, Qin L, Huang K, Wang
L, Huang W, Li S, Jia B, Zhong M, et al: Low immunogenicity of
neural progenitor cells differentiated from induced pluripotent
stem cells derived from less immunogenic somatic cells. PLoS One.
8:e696172013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu Y, Wu T, Song J, Chen X, Zhang Y and
Wan Y: A mutant screening method by critical annealing
temperature-PCR for site-directed mutagenesis. BMC Biotechnol.
13:212013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu P, Zhang Y, Chen S, Cai J and Pei D:
Application of iPS cells in dental bioengineering and beyond. Stem
Cell Rev. 10:663–670. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yao Q, Pei Y, Zhang X and Xie B:
microRNA-96 acts as a tumor suppressor gene in human osteosarcoma
via target regulation of EZRIN. Life Sci. 203:1–11. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen K, Liu MX, Mak CS, Yung MM, Leung TH,
Xu D, Ngu SF, Chan KK, Yang H, Ngan HY and Chan DW:
Methylation-associated silencing of miR-193a-3p promotes ovarian
cancer aggressiveness by targeting GRB7 and MAPK/ERK pathways.
Theranostics. 8:423–436. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jin X, Sun Y, Yang H, Li J, Yu S, Chang X,
Lu Z and Chen J: Deregulation of the MiR-193b-KRAS axis contributes
to impaired cell growth in pancreatic cancer. PLoS One.
10:e01255152015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gastaldi C, Bertero T, Xu N, Lebrigand K,
Fourre S, Popa A, Cardot-Leccia N, Meneguzzi G, Sonkoly E, et al:
miR-193b/365a cluster controls progression of epidermal squamous
cell carcinoma. Carcinogenesis. 35:1110–1120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li J, Kong F, Wu K, Song K, He J and Sun
W: miR-193b directly targets STMN1 and uPA genes and suppresses
tumor growth and metastasis in pancreatic cancer. Mol Med Rep.
10:2613–2620. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lü L, Liu T, Gao J, Zeng H, Chen J, Gu X
and Mei Z: Aberrant methylation of microRNA-193b in human Barrett's
esophagus and esophageal adenocarcinoma. Mol Med Rep. 14:283–288.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mitra AK, Chiang CY, Tiwari P, Tomar S,
Watters KM, Peter ME and Lengyel E: Microenvironment-induced
downregulation of miR-193b drives ovarian cancer metastasis.
Oncogene. 34:5923–5932. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Moore C, Parrish JK and Jedlicka P:
MiR-193b, downregulated in Ewing Sarcoma, targets the ErbB4
oncogene to inhibit anchorage-independent growth. PLoS One.
12:e01780282017. View Article : Google Scholar : PubMed/NCBI
|
